Adelene Q. Perkins

This profile gathers the share dealings of Adelene Q. Perkins across 2 companies, led by Infinity Pharmaceuticals, Inc. and Bruker Corp. The record holds 125 filings, for trades running from 12 September 2006 to 15 February 2026.

In open-market terms, that means 89 purchases worth €845k on one side and 12 sales worth €2.2M on the other. Taken together, the sales exceed the purchases by €1.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 16 share grants and 8 option exercises.

A typical purchase (the median) is worth €5,160.

The record was last updated on 18 February 2026 with a share grant in Bruker Corp. The last insider purchase was made public on 17 December 2010, 5,789 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.